CAJ | 학술논문

越来越多的研究发现,EB病毒(EBV)感染与淋巴瘤的发生、发展、治疗及预后有着密切关系.EBV阳性淋巴瘤的治疗主要以放化疗为基础,应用更昔洛韦、阿昔洛韦等核苷类抗病毒药物.近年新的治疗方法也不断涌现,如CDTO单克隆抗体、丁酸盐等,而预防EBV感染的惟一途径是接种抗病毒疫苗.EBV阳性淋巴瘤的标准治疗尚待进一步深入研究.
월래월다적연구발현,EB병독(EBV)감염여림파류적발생、발전、치료급예후유착밀절관계.EBV양성림파류적치료주요이방화료위기출,응용경석락위、아석락위등핵감류항병독약물.근년신적치료방법야불단용현,여CDTO단극륭항체、정산염등,이예방EBV감염적유일도경시접충항병독역묘.EBV양성림파류적표준치료상대진일보심입연구.
More and more studies have found that EBV infection is closely related to the occurrence, development, treatment and prognosis of lymphoma. The treatment of EBV-positive lymphoma bases mainly on combined chemo-radiotherapy together with ganciclovir, acyclovir and other antiviral drugs. Also there are novel ways to treat EBV positive- lymphoma including CD70 monoclonal antibody, butyrate, etc. The only way to prevent EBV infection is to inoculate anti-viral vaccine. The criterion of treating EBV positive-lymphoma remains to be further investigated.